Starwood Waypoint Homes to Release Third Quarter 2017 Financial Results
Get Alerts SFR Hot Sheet
Join SI Premium – FREE
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Starwood Waypoint Homes (NYSE: SFR) (the “Company”), a leading single-family rental real estate investment trust (“REIT”), will release its third quarter 2017 results after the market close on Wednesday, November 8, 2017. The Company will host a conference call on Thursday, November 9, 2017 at 10:00 a.m. Eastern Time to review the Company’s third quarter financial and operating results, provide a Company update and conduct a question-and-answer session.
Webcast:
- A link to access the conference call will be available in the Investor Relations section of the Company’s website at www.starwoodwaypoint.com.
- To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software.
To Participate in the Telephone Conference Call:
- Dial in at least 5 minutes prior to start time:
- Domestic: 1-877-407-9039
- International: 1-201-689-8470
Conference Call Playback:
- Domestic: 1-844-512-2921
- International: 1-412-317-6671
- Passcode: 13672436
- The playback will be available through December 9, 2017
About Starwood Waypoint Homes
Starwood Waypoint Homes is one of the largest publicly traded owners and operators of single-family rental homes in the United States. Starwood Waypoint Homes acquires, renovates, leases, maintains and manages single-family homes in markets that exhibit favorable demographics and long-term economic trends, as well as strengthening demand for rental properties.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171017006877/en/
Starwood Waypoint Homes
Investor Relations
Phone:
480-800-3490
Email: [email protected]
Source: Starwood Waypoint Homes
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- BMO starts chip stocks coverage: Here are its preferred picks
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share